Use of PKC inhibitors in particular indolylmaleimide derivatives in ocular diseases

Details for Australian Patent Application No. 2007286817 (hide)

Owner Novartis AG

Inventors Wagner, Jurgen; Sivak, Jeremy Michael

Agent Davies Collison Cave

Pub. Number AU-A-2007286817

PCT Pub. Number WO2008/024734

Priority 60/823,298 23.08.06 US; 60/914,899 30.04.07 US

Filing date 21 August 2007

Wipo publication date 28 February 2008

International Classifications

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/499 (2006.01) - Spiro-condensed pyrazines or piperazines

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/024734 Priority application(s): WO2008/024734

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286823-Computer graphics processing methods and systems for presentation of graphics objects or text in a wagering environment

2007286808-Aza-benzofuranyl compounds and methods of use